Your account is not claimed yet. You can sign up with ORCID to claim your account.

Emmy D G Fleuren

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 3

Top Topics

Childhood Cancer

Emergency Department

Dna Damage Response

Top Venues

Molecular cancer therapeutics

Expert opinion on investigational drugs

University of New South Wales

Radboud University Nijmegen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of New South Wales Sep 16o 2019

Australia

Conjoint Senior Lecturer :: School Women's and Children's Health, UNSW Medicine

Education History

Radboud University Nijmegen - Dec 22o 2014

Netherlands

PHD :: Medical Sciences

Publications

Emmy D G Fleuren, Rachael L Terry, Deborah Meyran, Natacha Omer, Joseph A Trapani, Michelle Haber, Paul J Neeson, Paul G Ekert
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors. Biomedicines 9 (12) (2021)
Yvonne M H Versleijen-Jonkers, Yvonne M H Versleijen-Jonkers, Winette T A van der Graaf, Emmy D G Fleuren
Targeted Therapy-based Combination Treatment in Rhabdomyosarcoma. Molecular cancer therapeutics 17 (7) (2019)
Inger Brandsma, Emmy D G Fleuren, Chris T Williamson, Christopher J Lord
Directing the use of DDR kinase inhibitors in cancer treatment. Expert opinion on investigational drugs 26 (12) (2017)